Taiwan Bio Therapeutics Co., Ltd (6892.TWO)
TWD 29.0
(-17.14%)
TWD 29.0
(-17.14%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 328.47 Million TWD | -4.56% |
| 2022 | 344.17 Million TWD | 3.16% |
| 2021 | 333.63 Million TWD | 151.89% |
| 2020 | 132.45 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 343.31 Million TWD | -0.25% |
| 2023 FY | 328.47 Million TWD | -4.56% |
| 2023 Q4 | 328.47 Million TWD | -4.32% |
| 2022 FY | 344.17 Million TWD | 3.16% |
| 2022 Q4 | 344.17 Million TWD | 0.0% |
| 2021 FY | 333.63 Million TWD | 151.89% |
| 2020 FY | 132.45 Million TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -4596.454% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 43.705% |
| Level Biotechnology Inc. | 273.2 Million TWD | -20.23% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -138.326% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | -66.338% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 75.263% |
| GlycoNex Incorporation | 276.39 Million TWD | -18.839% |
| VBI | 21.25 Million TWD | -1445.668% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | -4.706% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 36.176% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -1447.489% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 10.822% |
| Visgeneer Inc. | 185.6 Million TWD | -76.973% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 75.176% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 55.187% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -174.045% |
| Neith Corporation | 17.43 Million TWD | -1784.185% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 85.376% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -4863.282% |
| Enimmune corporation | 173.46 Million TWD | -89.36% |
| TaiRx, Inc. | 60.62 Million TWD | -441.806% |
| CHO Pharma, Inc. | 110.83 Million TWD | -196.367% |
| EirGenix Inc. | 1.14 Billion TWD | 71.315% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -193.327% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 35.9% |
| Lin BioScience, Inc. | 167.73 Million TWD | -95.833% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -250.503% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -421.1% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -163.347% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -103.944% |
| RBC Bioscience Corporation | 513.08 Million TWD | 35.981% |
| BiOptic Inc. | 170.56 Million TWD | -92.58% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -679.14% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -1312.47% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -1125.04% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 66.298% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -4020.296% |
| NaviFUS Corp. | 53.4 Million TWD | -515.101% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 31.78% |
| Sinew Pharma Inc. | 39.71 Million TWD | -727.089% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -465.947% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 9.879% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -44.259% |
| AP Biosciences Inc | 106.65 Million TWD | -207.989% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 90.695% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -970.597% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | -67.595% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 78.715% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 62.089% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -3441.074% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -488.519% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -40.999% |
| TCI GENE Inc. | 155.54 Million TWD | -111.17% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -1187.714% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -611.359% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -406.219% |
| PharmaEngine, Inc. | 91 Million TWD | -260.932% |
| Savior Lifetec Corporation | 457.95 Million TWD | 28.275% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -196.079% |
| OBI Pharma, Inc. | 650.44 Million TWD | 49.501% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 15.952% |
| Acepodia, Inc. | 384.47 Million TWD | 14.566% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -283.937% |